Advertisement
Research Article

Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia

  • Zheng Hu equal contributor,

    equal contributor Contributed equally to this work with: Zheng Hu, Xiao-Fen Pan, Fu-Qun Wu, Li-Yuan Ma

    Affiliation: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

    X
  • Xiao-Fen Pan equal contributor,

    equal contributor Contributed equally to this work with: Zheng Hu, Xiao-Fen Pan, Fu-Qun Wu, Li-Yuan Ma

    Affiliation: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

    X
  • Fu-Qun Wu equal contributor,

    equal contributor Contributed equally to this work with: Zheng Hu, Xiao-Fen Pan, Fu-Qun Wu, Li-Yuan Ma

    Affiliation: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

    X
  • Li-Yuan Ma equal contributor,

    equal contributor Contributed equally to this work with: Zheng Hu, Xiao-Fen Pan, Fu-Qun Wu, Li-Yuan Ma

    Affiliation: State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    X
  • Da-Peng Liu,

    Affiliation: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

    X
  • Ying Liu,

    Affiliations: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China, University of Science and Technology of China, Hefei, China

    X
  • Ting-Ting Feng,

    Affiliations: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China, University of Science and Technology of China, Hefei, China

    X
  • Fan-Yi Meng,

    Affiliation: Department of Hematology, Nanfang Hospital Affiliated to Nanfang Medical University, Guangzhou, China

    X
  • Xiao-Li Liu,

    Affiliation: Department of Hematology, Nanfang Hospital Affiliated to Nanfang Medical University, Guangzhou, China

    X
  • Qian-Li Jiang,

    Affiliation: Department of Hematology, Nanfang Hospital Affiliated to Nanfang Medical University, Guangzhou, China

    X
  • Xiao-Qin Chen,

    Affiliation: Department of Hematology, the Cancer Hospital, Sun Yat-Sen University, Guangzhou, China

    X
  • Jing-Lei Liu,

    Affiliations: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China, University of Science and Technology of China, Hefei, China

    X
  • Ping Liu,

    Affiliation: State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    X
  • Zhu Chen,

    Affiliation: State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    X
  • Sai-Juan Chen mail,

    sjchen@stn.sh.cn (SJC); gbzhou@ioz.ac.cn (GBZ)

    Affiliation: State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    X
  • Guang-Biao Zhou mail

    sjchen@stn.sh.cn (SJC); gbzhou@ioz.ac.cn (GBZ)

    Affiliations: Laboratory of Molecular Target-Based Therapy for Cancer, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China, Laboratory of Molecular Carcinogenesis and Targeted Therapy for Cancer, State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China

    X
  • Published: July 16, 2009
  • DOI: 10.1371/journal.pone.0006257

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.